Pityriasis lichenoides

Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment review. Am J Clin Dermatol. 2007;8(1):29-36. Abstract

Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006 Oct;55(4):557-72; quiz 573-6. Abstract

Bellinato F, Maurelli M, Gisondi P, et al. A systematic review of treatments for pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2039-49. Abstract

Jung F, Sibbald C, Bohdanowicz M, et al. Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020 Dec;183(6):1026-32. Abstract

1. Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment review. Am J Clin Dermatol. 2007;8(1):29-36. Abstract

2. Halbesleben JJ, Swick BL. Localized acral pityriasis lichenoides chronica: report of a case. J Dermatol. 2011 Aug;38(8):832-4. Abstract

3. Blyumin ML, Khachemoune A. What caused these excoriated papules? Diagnosis: pityriasis lichenoides et varioliformis acuta (PLEVA). Skin and Aging. 2004;12:99-102.

4. Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006 Oct;55(4):557-72; quiz 573-6. Abstract

5. Ersoy-Evans S, Greco F, Mancini A, et al. Pityriasis lichenoides in childhood: A retrospective review of 124 patients. J Am Acad Dermatol. 2007 Feb;56(2):205-10. Abstract

6. Elbendary A, Youssef R, Abdel-Halim MRE, et al. Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial. Arch Dermatol Res. 2023 Apr;315(3):521-30.Full text  Abstract

7. Jowkar F, Namazi MR, Bahmani M, et al. Triggering of pityriasis lichenoides et varioliformis acuta by radiocontrast iodide. J Dermatolog Treat. 2008;19(4):249-50. Abstract

8. Massay RJ, Maynard AA. Pityriasis lichenoides chronica associated with use of HMG-CoA reductase inhibitors. West Indian Med J. 2012 Oct;61(7):743-5. Abstract

9. Said BB, Kanitakis J, Graber I, et al. Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: report of 2 cases successfully treated with methotrexate. Inflamm Bowel Dis. 2010 Jun;16(6):912-3.

10. López-Ferrer A, Puig L, Moreno G, et al. Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate. Eur J Dermatol. 2010 Jul-Aug;20(4):511-2.

11. Clayton R, Haffenden G. An immunofluorescence study of pityriasis lichenoides. Br J Dermatol. 1978 Nov;99(5):491-3. Abstract

12. Muhlbauer JE, Bhan AK, Harrist TJ, et al. Immunopathology of pityriasis lichenoides acuta. J Am Acad Dermatol. 1984 May;10(5 Pt 1):783-95. Abstract

13. Dereure O, Levi E, Kadin ME. T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000 Dec;136(12):1483-6.Full text  Abstract

14. Di Giunta G, da Silva AM, Sotto MN. Inducible nitric oxide synthase in pityriasis lichenoides lesions. J Cutan Pathol. 2009 Mar;36(3):325-30. Abstract

15. Brazzini B, Ghersetich I, Urso C, et al. Pityriasis lichenoides et varioliformis acuta during pregnancy. J Eur Acad Dermatol Venereol. 2001 Sep;15(5):458-60. Abstract

16. Inamdar AC, Palit A. Koebner phenomenon in PLEVA. Indian J Dermatol Venereol Leprol. 2003 May-Jun;69(3):226. Abstract

17. Iba Y, Sugimoto K, Sakata N, et al. A child with PFAPA syndrome complicated by pityriasis lichenoides et varioliformis acuta. Pediatr Dermatol. 2011 Mar-Apr;28(2):207-9. Abstract

18. Errichetti E, Lacarrubba F, Micali G et al. Differentiation of pityriasis lichenoides chronica from guttate psoriasis by dermoscopy. Clin Exp Dermatol. 2015 Oct;40(7):804-6. Abstract

19. Cozzio A, Hafner J, Kempf W, et al. Febrile ulceronecrotic Mucha-Habermann disease with clonality: A cutaneous T-cell lymphoma entity? J Am Acad Dermatol. 2004 Dec;51(6):1014-7. Abstract

20. Nair PS. A clinical and histopathological study of pityriasis lichenoides. Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):100-2.Full text  Abstract

21. Raghavan SS, Wang JY, Gru AA, et al. Next-generation sequencing confirms T-cell clonality in a subset of pediatric pityriasis lichenoides. J Cutan Pathol. 2022 Mar;49(3):252-60. Abstract

22. American Society of Dermatopathology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2021 [internet publication].Full text

23. Kim HS, Yu DS, Kim JW. A case of febrile ulceronecrotic Mucha-Habermann's disease successfully treated with oral cyclosporine. JEADV. 2007 Feb;21(2):272-3. Abstract

24. Smith KJ, Nelson A, Skelton H, et al. Pityriasis lichenoides et varioliformis acuta in HIV-1 + patient: a marker of early stage disease. Int J Dermatol. 1997 Feb;36(2):104-9. Abstract

25. Bellinato F, Maurelli M, Gisondi P, et al. A systematic review of treatments for pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2039-49. Abstract

26. Jung F, Sibbald C, Bohdanowicz M, et al. Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020 Dec;183(6):1026-32. Abstract

27. Goulden V, Ling TC, Babakinejad P, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022. Br J Dermatol. 2022 Sep;187(3):295-308.Full text

28. Pavlotsky F, Baum S, Barzilai A, et al. UVB therapy of pityriasis lichenoides-our experience with 29 patients. J Eur Acad Dermatol Venereol. 2006 May;20(5):542-7. Abstract

29. Pyrpasopoulou A, Athyros VG, Karagiannis A, et al. Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease. Dermatology. 2007;215(2):164-5. Abstract

30. Simon D, Boudny C, Nievergelt H, et al. Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol. 2004 May;150(5):1033-5. Abstract

31. Tsianakas A, Hoeger PH. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumor necrosis factor-alpha. Br J Dermatol. 2005 Apr;152(4):794-9. Abstract

32. Nikkels AF, Gillard P, Piérard GE. Etanercept in therapy multiresistant overlapping pityriasis lichenoides. J Drugs Dermatol. 2008 Oct;7(10):990-2. Abstract

33. Romani J, Puig L, Fernandez-Figueras MT, et al. Pityriasis lichenoides in children: clinicopathologic review of 22 patients. Pediatr Dermatol. 1998 Jan-Feb;15(1):1-6. Abstract

34. Tasouli-Drakou V, Nguyen M, Guinn H, et al. Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications. Dermatol Reports. 2022 Nov 21;14(4):9492.Full text  Abstract

35. Verhamme T, Arnaout A, Ayliffe WH. Limbal and bulbar inflammatory nodules in a patient with pityriasis lichenoides et varioliformis acuta. Bull Soc Belge Ophtalmol. 2008;(307):13-8. Abstract

36. Moisseiev E, Varssano D. Conjunctival inflammatory nodule in a patient with pityriasis lichenoides et varioliformis acuta. Case Rep Dermatol. 2010 Jul 12;2(2):125-129.Full text  Abstract